NASDAQ:BTCY Biotricity (BTCY) Stock Price, News & Analysis $0.32 +0.04 (+14.55%) (As of 11/22/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends About Biotricity Stock (NASDAQ:BTCY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Biotricity alerts:Sign Up Key Stats Today's Range$0.27▼$0.3350-Day Range$0.20▼$0.5752-Week Range$0.19▼$1.67Volume68,044 shsAverage Volume78,078 shsMarket Capitalization$7.73 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company OverviewBiotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.Read More… I hate to say I told you so (Ad)Last month, I openly declared that a Trump Presidency was going to kick off Tesla’s New Bullish Cycle Folks who listened and bought in when I said to are currently crushing it. As a matter of fact, all the trades we’ve opened ever since I made that public declaration have ALL been winners. And it’s simply because this Tesla indicator just flipped green on the stock…Follow this link right away. Receive BTCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter. Email Address BTCY Stock News HeadlinesBiotricity's (BTCY) "Neutral" Rating Reiterated at HC WainwrightNovember 21 at 2:44 AM | americanbankingnews.comH.C. Wainwright Reaffirms Their Hold Rating on Biotricity (BTCY)November 19, 2024 | markets.businessinsider.comLet’s be bluntLet me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! November 23, 2024 | DTI (Ad)Biotricity (NASDAQ:BTCY) Trading Up 12.6% - Should You Buy?November 16, 2024 | americanbankingnews.comBiotricity Inc (BTCY) Q2 2025 Earnings Call Highlights: Milestone Achievements and Strategic GrowthNovember 16, 2024 | finance.yahoo.comBiotricity, Inc. (BTCY) Q2 2025 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comBiotricity Achieves Improved Margins and Efficiencies, and Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2025November 15, 2024 | globenewswire.comBiotricity to Host Second Quarter Fiscal Year 2025 Financial Results and Business Update Call on November 15thNovember 13, 2024 | globenewswire.comSee More Headlines BTCY Stock Analysis - Frequently Asked Questions How have BTCY shares performed this year? Biotricity's stock was trading at $1.15 at the start of the year. Since then, BTCY stock has decreased by 72.6% and is now trading at $0.3150. View the best growth stocks for 2024 here. How were Biotricity's earnings last quarter? Biotricity, Inc. (NASDAQ:BTCY) announced its quarterly earnings data on Thursday, June, 27th. The company reported ($0.47) EPS for the quarter, missing the consensus estimate of ($0.36) by $0.11. The firm earned $3.18 million during the quarter, compared to analyst estimates of $3.20 million. When did Biotricity IPO? Biotricity (BTCY) raised $15 million in an IPO on Thursday, August 26th 2021. The company issued 5,000,000 shares at a price of $3.00 per share. H.C. Wainwright & Co. served as the underwriter for the IPO. How do I buy shares of Biotricity? Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Biotricity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include TransDigm Group (TDG), Taiwan Semiconductor Manufacturing (TSM), Wix.com (WIX), Datadog (DDOG), Quanta Services (PWR), PayPal (PYPL) and Royal Caribbean Cruises (RCL). Company Calendar Last Earnings6/27/2024Today11/23/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:BTCY CUSIPN/A CIK1630113 Webwww.biotricity.com Phone(800) 590-4155FaxN/AEmployees40Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.37) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,090,000.00 Net Margins-97.05% Pretax Margin-97.04% Return on EquityN/A Return on Assets-221.26% Debt Debt-to-Equity RatioN/A Current Ratio0.19 Quick Ratio0.10 Sales & Book Value Annual Sales$12.06 million Price / Sales0.64 Cash FlowN/A Price / Cash FlowN/A Book Value($1.38) per share Price / Book-0.23Miscellaneous Outstanding Shares24,555,000Free Float20,331,000Market Cap$7.73 million OptionableOptionable Beta1.22 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:BTCY) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotricity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.